Munich - Delayed Quote • EUR
Celldex Therapeutics Inc (TCE2.MU)
At close: April 19 at 8:00 AM GMT+2
Loading Chart for TCE2.MU
DELL
- Previous Close
36.80 - Open
35.60 - Bid 35.60 x --
- Ask 35.80 x --
- Day's Range
35.60 - 35.60 - 52 Week Range
21.20 - 47.20 - Volume
55 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 2, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: TCE2.MU
Performance Overview: TCE2.MU
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
TCE2.MU
0.00%
S&P 500
4.14%
1-Year Return
TCE2.MU
20.27%
S&P 500
19.55%
3-Year Return
TCE2.MU
83.60%
S&P 500
18.68%
5-Year Return
TCE2.MU
933.38%
S&P 500
70.99%
Compare To: TCE2.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TCE2.MU
Valuation Measures
As of 4/19/2024
Market Cap
2.37B
Enterprise Value
1.97B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
276.36
Price/Book (mrq)
6.01
Enterprise Value/Revenue
286.93
Enterprise Value/EBITDA
-14.20
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--